Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Sprache: Englisch
ISBN 10: 0443035946 ISBN 13: 9780443035944
Anbieter: Hamelyn, Madrid, M, Spanien
Zustand: Como nuevo. : Este libro, titulado 'Hypertension - The Next Decade: Verapamil in Focus', es una recopilación de las actas de un simposio internacional celebrado en Berlín en octubre de 1985. Editado por A. Fleckenstein y John H. Laragh, aborda temas relacionados con la hipertensión y el uso de verapamilo. Publicado en 1987 por Churchill Livingstone, el libro está en inglés y contiene 381 páginas. EAN: 9780443035944 Tipo: Libros Categoría: Salud y Bienestar Título: Hypertension - The Next Decade Autor: Albrecht Fleckenstein| John H. Laragh Editorial: Churchill Livingstone Idioma: en Páginas: 381 Formato: tapa blanda.
EUR 43,93
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. 276 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.
Verlag: Rx Concepts
Anbieter: Robinson Street Books, IOBA, Binghamton, NY, USA
Verbandsmitglied: IOBA
Zustand: Very Good. Prompt Shipment, shipped in Boxes, Tracking PROVIDEDVery good VHS in case with workbook.
Sprache: Englisch
Verlag: Lippincott Williams and Wilkins, 1989
ISBN 10: 0881675342 ISBN 13: 9780881675344
Anbieter: NEPO UG, Rüsselsheim am Main, Deutschland
Gebundene Ausgabe. Zustand: Gut. 683 Seiten ex Library Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
EUR 105,19
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Sprache: Englisch
Verlag: Lippincott Williams & Wilkins, 1995
ISBN 10: 0781701570 ISBN 13: 9780781701570
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 124,74
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. pp. 3219.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1998
ISBN 10: 3540635424 ISBN 13: 9783540635420
Anbieter: moluna, Greven, Deutschland
EUR 92,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbKartoniert / Broschiert. Zustand: New.
Sprache: Englisch
Verlag: HP Publishing Co Inc.,U.S., 1977
ISBN 10: 0913800074 ISBN 13: 9780913800072
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 274 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.
EUR 149,85
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 271 pages. 9.50x6.25x0.50 inches. In Stock.
Anbieter: GridFreed, San Diego, CA, USA
hardcover. Zustand: Good. Good with wear and markings. Looks like an interesting title!
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1998
ISBN 10: 3540635424 ISBN 13: 9783540635420
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure).